External News
- MedPageToday
Moving Newer Agents Up Earlier in Advanced Bladder Cancer
- Healthline
Prostate Cancer: Why Digital Rectal Exams Alone Aren't Accurate in Detecting the Disease
- OncLive
Dr. Braun on the Role of SLAMF7+ CD8+ T-cells in Nivolumab-Resistant RCC
- WTNH
Health Headlines: Yale urologist discusses bladder cancer drug shortage
- The ASCO Post
Daniel P. Petrylak, MD, on Prostate Cancer: Latest Data on Pembrolizumab Plus Docetaxel
- Yale New Haven Health News
Bladder Cancer Support Group Using Virtual Connections to Help Patients
- Yale Daily News
“You can’t be what you can’t see”: A look at female representation in Yale’s administrative leadership
- News Talk 1490AM WGCH
Dr. Petrylak Speaks on Bladder Cancer
- Urology Times
Experts Study Implications of Genetic Markers in Prostate Cancer
- PBN
Five Questions With: Dr. Joseph Renzulli, Dr. Sanjay Aneja and Dr. Matthew Austin
